IOVA FY 2015 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$999,000

Operating Income

-$28M

Net Income

-$28M

EPS (Diluted)

$-0.62

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$20M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$106M

Total Liabilities

$2M

Stockholders' Equity

$104M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$999,000	-$9M	+89.3%
Operating Income	-$28M	-$12M	-131.4%
Net Income	-$28M	-$12M	-129.8%